OP
Oramed Pharmaceuticals Inc
🇩🇪XSTU.OJU1GermanyHealthcare
€4.00EURup +0.04 (+1.01%)ClosedEnd of day1:25 AM
Price€4.00+0.04 (+1.01%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US68403P2039
- CUSIP
- Not reported
Company
- Employees
- 0
- Headquarters
- New York, United States
- Website
- https://oramed.com
- CEO
- Mr. Nadav Kidron Esq.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Nov 12, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- 10.43%
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- $174.87M+823.74%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$5.37M+66.66%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.